Aptorum Group up on reverse stock split plan
Brief: Aptorum Group Announces Reverse Stock Split
Brief: Aptorum Group Ltd Files For Mixed Shelf Of Up To $125 Million- SEC Filing
U.S. STOCKS ON THE MOVE-First Wave BioPharma, Energy firms, Brookdale Senior Living
U.S. STOCKS ON THE MOVE-Cano Health, DexCom, Conagra Brands
U.S. STOCKS ON THE MOVE-Akero, Ambac, Aptorum
H.C. Wainwright starts Aptorum coverage with 'buy'; shares up
Brief: Aptorum Group Ltd Says Darren Lui, Co's President And Executive Director, Has Been Appointed Chief Executive Officer, Effective June 1, 2022
Brief: Aptorum Group Updates On Data From The Completed Phase 1 Clinical Trial Of Sact-1
U.S. STOCKS ON THE MOVE-Tesla, Mastercard, American Express
U.S. STOCKS ON THE MOVE-American Express, Nvidia, 3M
U.S. STOCKS ON THE MOVE- 3M, IBM, airline stocks
U.S. STOCKS ON THE MOVE-Blue Apron, Baker Hughes, Luminar, cruise cos
Aptorum jumps on FDA orphan drug tag for cancer treatment
Brief: Aptorum Group Granted First Patent For Its SACT-1 Repurposed Drug
Brief: Aptorum Group Limited Receives IND Clearance From U.S. FDA to Initiate Clinical Trials for Treatment of Neuroblastoma
Brief: Aptorum Group Announces Further Positive Interim Results Of Phase 1 Clinical Trial Of ALS-4
CEO Ian Huen Has Purchased 1.39 Million Class A Ordinary Shares In Co At $2.882 Per Share
Aptorum Group shares climb after drug study data